Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 2
2012 1
2014 2
2015 1
2016 3
2017 4
2020 1
2021 3
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation.
Messelodi D, Strocchi S, Bertuccio SN, Baden P, Indio V, Giorgi FM, Taddia A, Serravalle S, Valente S, di Fonzo A, Frattini E, Bernardoni R, Pession A, Grifoni D, Deleidi M, Astolfi A, Pession A. Messelodi D, et al. Among authors: serravalle s. Commun Biol. 2023 Apr 19;6(1):431. doi: 10.1038/s42003-023-04813-2. Commun Biol. 2023. PMID: 37076591 Free PMC article.
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).
Fiore M, Taddia A, Indio V, Bertuccio SN, Messelodi D, Serravalle S, Bandini J, Spreafico F, Perotti D, Collini P, Di Cataldo A, Pasquinelli G, Chiarini F, Fois M, Melchionda F, Pession A, Astolfi A. Fiore M, et al. Among authors: serravalle s. Int J Mol Sci. 2023 Feb 13;24(4):3743. doi: 10.3390/ijms24043743. Int J Mol Sci. 2023. PMID: 36835166 Free PMC article.
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.
Brandi G, Relli V, Deserti M, Palloni A, Indio V, Astolfi A, Serravalle S, Mattiaccio A, Vasuri F, Malvi D, Deiana C, Pantaleo MA, Cescon M, Rizzo A, Katoh M, Tavolari S. Brandi G, et al. Among authors: serravalle s. Sci Rep. 2024 Feb 7;14(1):3136. doi: 10.1038/s41598-024-52991-8. Sci Rep. 2024. PMID: 38326380 Free PMC article.
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Gottardi F, Baccelli F, Leardini D, Di Battista A, Castellucci P, D'Amico D, Serravalle S, Bertuccio SN, Messelodi D, Prete A, Masetti R. Gottardi F, et al. Among authors: serravalle s. Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37350036 No abstract available.
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R, Bertuccio SN, Astolfi A, Chiarini F, Lonetti A, Indio V, De Luca M, Bandini J, Serravalle S, Franzoni M, Pigazzi M, Martelli AM, Basso G, Locatelli F, Pession A. Masetti R, et al. Among authors: serravalle s. J Hematol Oncol. 2017 Jan 21;10(1):26. doi: 10.1186/s13045-017-0396-0. J Hematol Oncol. 2017. PMID: 28109323 Free PMC article.
23 results